The update on transcatheter arterial chemoembolization using drug-eluting beads: Optimization for best response

키워드

참고문헌 (31)

1. Prajapati HJ, "Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC", AJR Am J Roentgenol, 203, pp.W706~W714 (2014)
2. Irie T, "Diameter of main tumor feeding artery of a hepatocellular carcinoma: measurement at the entry site into the nodule", Hepatol Res, 46, pp.E100~E104 (2016)
3. Namur J, "Embolization of hepatocellular carcinoma with drug-eluting beads: doxorubicin tissue concentration and distribution in patient liver explants", J Hepatol, 55, pp.1332~1338 (2011)
4. Richter G, "Safety and feasibility of chemoembolization with doxorubicin-loaded small calibrated microspheres in patients with hepatocellular carcinoma: results of the MIRACLE I prospective multicenter study", Cardiovasc Intervent Radiol, 41, pp.587~593 (2018)
5. Aliberti C, "Transarterial chemoembolization with small drug-eluting beads in patients with hepatocellular carcinoma: experience from a cohort of 421 patients at an Italian center", J Vasc Interv Radiol, 28, pp.1495~1502 (2017)
6. Spreafico C, "Transarterial chemoembolization for hepatocellular carcinoma with a new generation of beads: clinical-radiological outcomes and safety profile", Cardiovasc Intervent Radiol, 38, pp.129~134 (2015)
7. Gao S, "Doxorubicin-eluting bead versus conventional TACE for unresectable hepatocellular carcinoma: a metaanalysis", Hepatogastroenterology, 60, pp.813~820 (2013)
8. Huang K, "Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma", J Gastroenterol Hepatol, 29, pp.920~925 (2014)
9. Xie ZB, "Systematic review comparing the safety and efficacy of conventional and drug-eluting bead transarterial chemoembolization for inoperable hepatocellular carcinoma", Hepatol Res, 45, pp.190~200 (2015)
10. Chen P, "Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: a systematic review and meta-analysis", Clin Res Hepatol Gastroenterol, 41, pp.75~85 (2017)
11. Facciorusso A, "Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: a meta-analysis", Dig Liver Dis, 48, pp.571~577 (2016)
12. Golfieri R, "Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma", Br J Cancer, 111, pp.255~264 (2014)
13. Varela M, "Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics", J Hepatol, 46, pp.474~481 (2007)
14. Lencioni R, "Transcatheter treatment of hepatocellular carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): technical recommendations", Cardiovasc Intervent Radiol, 35, pp.980~985 (2012)
15. Malagari K, "Drug-eluting particles in the treatment of HCC: chemoembolization with doxorubicin-loaded DC Bead", Expert Rev Anticancer Ther, 8, pp.1643~1650 (2008)
16. Urbano J, "Multicentre prospective study of drug-eluting bead chemoembolisation safety using tightly calibrated small microspheres in non-resectable hepatocellular carcinoma", Eur J Radiol, 126, pp.108966~ (2020)
17. Galastri FL, "Imaging response predictors following drug eluting beads chemoembolization in the neoadjuvant liver transplant treatment of hepatocellular carcinoma", World J Hepatol, 12, pp.21~33 (2020)
18. Lee JH, "Transcatheter arterial chemoembolization of hepatocellular carcinoma with hepatic arteriovenous shunt after temporary balloon occlusion of hepatic vein", J Vasc Interv Radiol, 18, pp.377~382 (2007)
19. Lee S, "Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma:comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study", Acta Radiol, 58, pp.131~139 (2017)
20. Kobayashi N, "Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization", Liver, 19, pp.25~31 (1999)
21. Wang B, "Increased expression of vascular endothelial growth factor in hepatocellular carcinoma after transcatheter arterial chemoembolization", Acta Radiol, 49, pp.523~529 (2008)
22. Lee KH, "Distribution of iron oxide-containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy", J Vasc Interv Radiol, 19, pp.1490~1496 (2008)
23. Lee SY, "Drug-eluting bead transarterial chemoembolization for hepatocellular carcinoma: does size really matter?", Diagn Interv Radiol, 26, pp.230~235 (2020)
24. Dreher MR, "Radiopaque drug-eluting beads for transcatheter embolotherapy: experimental study of drug penetration and coverage in swine", J Vasc Interv Radiol, 23, pp.257~264.e4 (2012)
25. Lammer J, "Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study", Cardiovasc Intervent Radiol, 33, pp.41~52 (2010)
26. Malagari K, "Chemoembolization of hepatocellular carcinoma with HepaSphere 30-60 μm. Safety and efficacy study", Cardiovasc Intervent Radiol, 37, pp.165~175 (2014)
27. Vesselle G, "Predictive factors for complete response of chemoembolization with drug-eluting beads (DEB-TACE) for hepatocellular carcinoma", Eur Radiol, 26, pp.1640~1648 (2016)
28. Lee M, "Korean multicenter registry of transcatheter arterial chemoembolization with drug-eluting embolic agents for nodular hepatocellular carcinomas: six-month outcome analysis", J Vasc Interv Radiol, 28, pp.502~512 (2017)
29. Aal AKA, "Survival outcomes of very small drug-eluting beads used in chemoembolization of unresectable hepatocellular carcinoma", J Vasc Interv Radiol, 30, pp.1325~1334.e2 (2019)
30. Asayama Y, "Predictors of therapeutic effect of transarterial chemoembolisation using drug-eluting beads for hepatocellular carcinoma", Clin Radiol, 72, pp.780~785 (2017)
31. Bryant MK, "Computed tomography predictors of hepatocellular carcinoma tumour necrosis after chemoembolization", HPB (Oxford), 16, pp.327~335 (2014)

관련 논문AI추천